Cited by 109

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

A Cost Analysis of Hospitalizations for Infections Related to Injection Drug Use at a County Safety-Net Hospital in Miami, Florida

Tookes, Hansel, Diaz, Chanelle, Li, Hua, Khalid, Rafi, Doblecki-Lewis, Susanne·2015·PLOS ONE

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0129360

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 (A) demonstrates the relationship between the observed frequencies of infectious diagnoses. Euler diagram. (B) shows the charges per infection type and the proportion of the total charges.
Fig 1 (A) demonstrates the relationship between the observed frequencies of infectious diagnoses. Euler diagram. (B) shows the charges per infection type and the proportion of the total charges.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 31

  1. B Tempalski, 2009, HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992–2002, J Urban Health, 86, 132, 10.1007/s11524-008-9328-1 · DOI
  2. D Broz, 2014, HIV infection and risk, prevention, and testing behaviors among injecting drug users—National HIV Behavioral Surveillance System, 20 U.S. cities, 2009, MMWR Surveill Summ, 63, 1
  3. 2001, Soft tissue infections among injection drug users—San Francisco, California, 1996–2000, MMWR Morb Mortal Wkly Rep, 50, 381
  4. HP Simmen, 1995, Soft tissue infections of the upper extremities with special consideration of abscesses in parenteral drug abusers. A prospective study, J Hand Surg Br, 20, 797, 10.1016/S0266-7681(95)80050-6 · DOI
  5. RJ Gordon, 2005, Bacterial infections in drug users, N Engl J Med, 353, 1945, 10.1056/NEJMra042823 · DOI · Paper page
  6. KT Phillips, 2010, Risk practices associated with bacterial infections among injection drug users in Denver, Colorado, Am J Drug Alcohol Abuse, 36, 92, 10.3109/00952991003592311 · DOI
  7. AC Kimura, 2004, Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users, Clin Infect Dis, 38, e87, 10.1086/383471 · DOI
  8. S Lonergan, 2004, A case series of patients with black tar heroin-associated necrotizing fasciitis, J Emerg Med, 26, 47, 10.1016/j.jemermed.2003.06.003 · DOI
  9. E Hyshka, 2012, Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research, Int J Drug Policy, 23, 261, 10.1016/j.drugpo.2012.03.006 · DOI
  10. M Marks, 2013, Needles and the damage done: reasons for admission and financial costs associated with injecting drug use in a Central London Teaching Hospital, J Infect, 66, 95, 10.1016/j.jinf.2012.10.004 · DOI · Paper page
  11. R Sweeney, 2009, The economic burden to the public health system of treating non-viral injecting-related injury and disease in Australia (a cost of illness analysis), Aust N Z J Public Health, 33, 352, 10.1111/j.1753-6405.2009.00407.x · DOI
  12. JA Frontera, 2000, Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis, Clin Infect Dis, 30, 374, 10.1086/313664 · DOI
  13. V Jain, 2008, Infective endocarditis in an urban medical center: association of individual drugs with valvular involvement, J Infect, 57, 132, 10.1016/j.jinf.2008.05.008 · DOI
  14. G Saydain, 2010, Outcome of patients with injection drug use-associated endocarditis admitted to an intensive care unit, J Crit Care, 25, 248, 10.1016/j.jcrc.2009.09.007 · DOI
  15. AR Tunkel, 2002, Central nervous system infections in injection drug users, Infect Dis Clin North Am, 16, 589, 10.1016/S0891-5520(02)00015-6 · DOI
  16. KG Heinzerling, 2006, Hospital utilization for injection drug use-related soft tissue infections in urban versus rural counties in California, J Urban Health, 83, 176, 10.1007/s11524-005-9021-6 · DOI
  17. A Palepu, 2001, Hospital utilization and costs in a cohort of injection drug users, CMAJ, 165, 415
  18. TA Takahashi, 2010, US hospitalizations and costs for illicit drug users with soft tissue infections, J Behav Health Serv Res, 37, 508, 10.1007/s11414-009-9177-z · DOI
  19. KA Gebo, 2005, Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states, J Acquir Immune Defic Syndr, 40, 609, 10.1097/01.qai.0000171727.55553.78 · DOI
  20. HL Cooper, 2007, Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis, Clin Infect Dis, 45, 1200, 10.1086/522176 · DOI
  21. L Micallef, 2014, eulerAPE: drawing area-proportional 3-Venn diagrams using ellipses, PLoS One, 9, e101717, 10.1371/journal.pone.0101717 · DOI
  22. JL Chen, 2001, Necrotizing fasciitis associated with injection drug use, Clin Infect Dis, 33, 6, 10.1086/320874 · DOI
  23. JR Ebright, 2002, Skin and soft tissue infections in injection drug users, Infect Dis Clin North Am, 16, 697, 10.1016/S0891-5520(02)00017-X · DOI · Paper page
  24. P Del Giudice, 2004, Cutaneous complications of intravenous drug abuse, Br J Dermatol, 150, 1, 10.1111/j.1365-2133.2004.05607.x · DOI · Paper page
  25. HW Harris, 2002, Care of injection drug users with soft tissue infections in San Francisco, California, Arch Surg, 137, 1217, 10.1001/archsurg.137.11.1217 · DOI · Paper page
  26. HK Belani, 2008, Cost-effectiveness of Needle and Syringe Exchange for the Prevention of HIV in New York City, J HIV/AIDS& Social Services, 7, 229, 10.1080/15381500802307492 · DOI
  27. M Gold, 1997, Needle exchange programs: an economic evaluation of a local experience, CMAJ, 157, 255
  28. DR Holtgrave, 1998, Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States, J Acquir Immune Defic Syndr Hum Retrovirol, 18, S133, 10.1097/00042560-199802001-00022 · DOI
  29. JA Kwon, 2012, Estimating the cost-effectiveness of needle-syringe programs in Australia, AIDS, 26, 2201, 10.1097/QAD.0b013e3283578b5d · DOI
  30. P Lurie, 1998, An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users, J Acquir Immune Defic Syndr Hum Retrovirol, 18, S126, 10.1097/00042560-199802001-00021 · DOI
  31. HE Tookes, 2012, A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs, Drug Alcohol Depend, 123, 255, 10.1016/j.drugalcdep.2011.12.001 · DOI

Cited by

Sorted by citations

See all 109

Metadata

Authors
Tookes, H., Diaz, C., Li, H., Khalid, R., & Doblecki-Lewis, S.
Venue
PLOS ONE
Published
2015-06-15
Volume
10
Issue
6
Pages
e0129360
ISSN
1932-6203
Cited by
109
References
9
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review